Advertisement

Acta Neurochirurgica

, Volume 160, Issue 5, pp 1073–1077 | Cite as

Intraventricular urokinase to treat a blocked ventriculoperitoneal shunt in a glioblastoma patient with leptomeningeal spread

  • Peter Y. M. Woo
  • James T. F. Zhuang
  • Jason M. K. Ho
  • Andrew Seto
  • Hoi-Tung Wong
  • Kwong-Yau Chan
Case Report - Brain Tumors
  • 81 Downloads
Part of the following topical collections:
  1. Brain tumors

Abstract

Leptomeningeal spread and hydrocephalus are increasingly recognized as late disease complications of glioblastoma with almost a quarter of patients requiring early cerebrospinal fluid shunting. The neurosurgeon is challenged with maintaining shunt patency when tumor disease progression is rapid and adjuvant oncologic therapy has yet to be initiated. We describe our experience in treating a young female with diffuse glioblastoma leptomeningeal spread and communicating hydrocephalus who had several episodes of shunt obstruction due to intraluminal tumor cell-fibrin deposits. Regular intraventricular instillations of urokinase fibrinolytic therapy not only re-established shunt patency but also contributed to the resolution of her hydrocephalus.

Keywords

Glioblastoma Leptomeningeal spread Hydrocephalus Fibrinolytic Urokinase 

Notes

Acknowledgments

This manuscript is dedicated to the patient CMY and was supported by the Tung Wah Group of Hospitals Clinical Research Center.

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

Informed consent

Informed consent was obtained from the individual participant included in the study.

References

  1. 1.
    Ando S, Moritake K (1989) Communicating hydrocephalus occurring in the postoperative course of glioblastoma multiforme. Nihon Geka Hokan 58:508–515PubMedGoogle Scholar
  2. 2.
    Arita N, Taneda M, Hayakawa T (1994) Leptomeningeal dissemination of malignant gliomas. Incidence, diagnosis and outcome. Acta Neurochir 126:84–92CrossRefPubMedGoogle Scholar
  3. 3.
    Brinker T, Seifert V, Dietz H (1992) Subacute hydrocephalus after experimental subarachnoid hemorrhage: its prevention by intrathecal fibrinolysis with recombinant tissue plasminogen activator. Neurosurgery 31:306–311 discussion 311-302CrossRefPubMedGoogle Scholar
  4. 4.
    Brydon HL, Hayward R, Harkness W, Bayston R (1995) Physical properties of cerebrospinal fluid of relevance to shunt function. 1: the effect of protein upon CSF viscosity. Br J Neurosurg 9:639–644CrossRefPubMedGoogle Scholar
  5. 5.
    Brydon HL, Hayward R, Harkness W, Bayston R (1995) Physical properties of cerebrospinal fluid of relevance to shunt function. 2: the effect of protein upon CSF surface tension and contact angle. Br J Neurosurg 9:645–651CrossRefPubMedGoogle Scholar
  6. 6.
    Brydon HL, Keir G, Thompson EJ, Bayston R, Hayward R, Harkness W (1998) Protein adsorption to hydrocephalus shunt catheters: CSF protein adsorption. J Neurol Neurosurg Psychiatry 64:643–647CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Castro BA, Imber BS, Chen R, McDermott MW, Aghi MK (2017) Ventriculoperitoneal shunting for glioblastoma: risk factors, indications, and efficacy. Neurosurgery 80:421–430PubMedGoogle Scholar
  8. 8.
    Cheatle JT, Bowder AN, Tefft JL, Agrawal SK, Hellbusch LC (2015) Effect of protein concentration on the flow of cerebrospinal fluid through shunt tubing. Neurosurgery 77:972–978CrossRefPubMedGoogle Scholar
  9. 9.
    Cinalli G, Sainte-Rose C, Lellouch-Tubiana A, Sebag G, Renier D, Pierre-Kahn A (1995) Hydrocephalus associated with intramedullary low-grade glioma. Illustrative cases and review of the literature. J Neurosurg 83:480–485CrossRefPubMedGoogle Scholar
  10. 10.
    Clark AJ, Lamborn KR, Butowski NA, Chang SM, Prados MD, Clarke JL, McDermott MW, Parsa AT, Berger MS, Aghi MK (2012) Neurosurgical management and prognosis of patients with glioblastoma that progresses during bevacizumab treatment. Neurosurgery 70:361–370CrossRefPubMedGoogle Scholar
  11. 11.
    Elliott JP, Keles GE, Waite M, Temkin N, Berger MS (1994) Ventricular entry during resection of malignant gliomas: effect on intracranial cerebrospinal fluid tumor dissemination. J Neurosurg 80:834–839CrossRefPubMedGoogle Scholar
  12. 12.
    Farb RI, Forghani R, Lee SK, Mikulis DJ, Agid R (2007) The venous distension sign: a diagnostic sign of intracranial hypotension at MR imaging of the brain. AJNR Am J Neuroradiol 28:1489–1493CrossRefPubMedGoogle Scholar
  13. 13.
    Foltz EL, Shurtleff DB (1963) Five-year comparative study of hydrocephalus in children with and without operation (113 cases). J Neurosurg 20:1064–1079.  https://doi.org/10.3171/jns.1963.20.12.1064 CrossRefPubMedGoogle Scholar
  14. 14.
    Grabb PA, Albright AL, Pang D (1992) Dissemination of supratentorial malignant gliomas via the cerebrospinal fluid in children. Neurosurgery 30:64–71CrossRefPubMedGoogle Scholar
  15. 15.
    Inamasu J, Nakamura Y, Saito R, Kuroshima Y, Mayanagi K, Orii M, Ichikizaki K (2003) Postoperative communicating hydrocephalus in patients with supratentorial malignant glioma. Clin Neurol Neurosurg 106:9–15CrossRefPubMedGoogle Scholar
  16. 16.
    Lam CH, Cosgrove GR, Drislane FW, Sotrel A (1991) Spinal leptomeningeal metastasis from cerebral glioblastoma. Appearance on magnetic resonance imaging. Surg Neurol 35:377–380CrossRefPubMedGoogle Scholar
  17. 17.
    Macdonald DR, Cascino TL, Schold SC Jr, Cairncross JG (1990) Response criteria for phase II studies of supratentorial malignant glioma. J Clin Oncol 8:1277–1280CrossRefPubMedGoogle Scholar
  18. 18.
    Maurice-Williams RS, Lucey JJ (1975) Raised intracranial pressure due to spinal tumours: 3 rare cases with a probable common mechanism. Br J Surg 62:92–95CrossRefPubMedGoogle Scholar
  19. 19.
    Muralidharan R (2015) External ventricular drains: management and complications. Surg Neurol Int 6:S271–S274CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    Noh JH, Lee MH, Kim WS, Lim DH, Kim ST, Kong DS, Nam DH, Lee JI, Seol HJ (2015) Optimal treatment of leptomeningeal spread in glioblastoma: analysis of risk factors and outcome. Acta Neurochir 157:569–576CrossRefPubMedGoogle Scholar
  21. 21.
    Occhipinti E, Carapella C (1982) Shunt failure in hydrocephalus with high protein fluid. Monog Neural Sci 8:220–222Google Scholar
  22. 22.
    Onda K, Tanaka R, Takahashi H, Takeda N, Ikuta F (1989) Cerebral glioblastoma with cerebrospinal fluid dissemination: a clinicopathological study of 14 cases examined by complete autopsy. Neurosurgery 25:533–540CrossRefPubMedGoogle Scholar
  23. 23.
    Shooman D, Vajramani GV, Davidson J, Sparrow OC (2010) Use of intrathecal urokinase in repeated shunt and external ventricular drain blockage from high CSF protein due to an optic pathway glioma. Childs Nerv Syst 26:607–611CrossRefPubMedGoogle Scholar
  24. 24.
    Staykov D, Kuramatsu JB, Bardutzky J, Volbers B, Gerner ST, Kloska SP, Doerfler A, Schwab S, Huttner HB (2017) Efficacy and safety of combined intraventricular fibrinolysis with lumbar drainage for prevention of permanent shunt dependency after intracerebral hemorrhage with severe ventricular involvement: a randomized trial and individual patient data meta-analysis. Ann Neurol 81:93–103CrossRefPubMedGoogle Scholar
  25. 25.
    Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U, Curschmann J, Janzer RC, Ludwin SK, Gorlia T, Allgeier A, Lacombe D, Cairncross JG, Eisenhauer E, Mirimanoff RO, European Organisation for R, Treatment of Cancer Brain T, Radiotherapy G, National Cancer Institute of Canada Clinical Trials G (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352:987–996Google Scholar

Copyright information

© Springer-Verlag GmbH Austria, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Department of NeurosurgeryKwong Wah HospitalYaumateiHong Kong

Personalised recommendations